Dr. Alireza Falahati Explores MWA Techniques in China

October 2024 — Dr. Alireza Falahati, a leading endocrinologist and Founder of Utah Endocrinology Associates, began the first day of his academic exchange at Sun Yat-sen University Cancer Center’s Ultrasound Department in Guangzhou, China. The visit included observing three live microwave ablation (MWA) procedures for thyroid nodules under the guidance of Dr. Jianhua Zhou and his expert team. The clinical team demonstrated the use of precision-guided MWA techniques for various thyroid nodule cases, showcasing their skill in delivering targeted energy with high accuracy.

Dr. Falahati was particularly impressed by the real-time adjustments and decision-making strategies during the procedures, which emphasized safety and efficiency, even in complex cases. He acknowledged the seamless coordination among the surgical team and the rapid, yet careful execution of the ablation process.

"I was impressed by the efficiency and precision of the Chinese surgical team. Their expertise and quick decision-making in managing complex cases are truly exemplary," stated Dr. Falahati. The discussions also included a review of MWA’s use in reducing the size of large nodules and minimizing post-procedural complications, such as scarring and vocal cord injury.

After his hospital visit, Dr. Falahati continued the exchange at Baird Medical’s Guangzhou headquarters. Here, he took part in a hands-on demonstration using Baird’s advanced MWA system on an animal liver and thyroid model, exploring its usability and temperature control features. The session provided further insights into the system’s potential for treating thyroid conditions in a clinical setting.

Dr. Falahati’s visit is the first day of a multi-day engagement designed to deepen academic collaboration and expand the global adoption of MWA for minimally invasive thyroid treatments.

Disclaimer:

This post is intended for informational purposes only and does not represent a formal endorsement or partnership between Sun Yat-sen University Cancer Center, Baird Medical, and the visiting physicians. The content shared reflects the preliminary stages of academic exchange and does not constitute a clinical recommendation or official adoption of Baird Medical’s products by the hospital or the attending physicians. All clinical references are specific to this demonstration and should not be used to generalize outcomes. Forward-looking statements are based on current expectations and involve inherent risks and uncertainties. Please refer to Baird Medical’s official disclosures for more information.